|
NTR2_HUMAN |
NTSR2 |
Neurotensin receptor type 2 |
1.306e-129 |
0.35
|
V2R_PIG |
AVPR2 |
Vasopressin V2 receptor |
1.896e-129 |
0.54
|
LSHR_RAT |
Lhcgr |
Lutropin-choriogonadotropic hormone receptor |
4.754e-100 |
0.35
|
Q5D7U5_CHICK |
OXTR |
Oxytocin-like receptor |
7.822e-100 |
0.80
|
NTR1_RAT |
Ntsr1 |
Neurotensin receptor type 1 |
1.083e-99 |
0.36
|
NTR1_HUMAN |
NTSR1 |
Neurotensin receptor type 1 |
1.905e-97 |
0.36
|
V2R_BOVIN |
AVPR2 |
Vasopressin V2 receptor |
4.407e-88 |
0.61
|
V1BR_HUMAN |
AVPR1B |
Vasopressin V1b receptor |
8.527e-88 |
0.88
|
OXYR_HUMAN |
OXTR |
Oxytocin receptor |
2.861e-77 |
0.88
|
HLAA_HUMAN |
HLA-A |
HLA class I histocompatibility antigen, A alpha chain |
7.088e-74 |
0.36
|
STAT3_HUMAN |
STAT3 |
Signal transducer and activator of transcription 3 |
4.119e-73 |
0.39
|
SORT_HUMAN |
SORT1 |
Sortilin |
9.471e-72 |
0.35
|
OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
1.387e-66 |
0.42
|
NTR1_MOUSE |
Ntsr1 |
Neurotensin receptor type 1 |
8.811e-65 |
0.36
|
LCAP_HUMAN |
LNPEP |
Leucyl-cystinyl aminopeptidase |
1.244e-61 |
0.48
|
SSR5_RAT |
Sstr5 |
Somatostatin receptor type 5 |
8.356e-55 |
0.31
|
HDAC5_MOUSE |
Hdac5 |
Histone deacetylase 5 |
6.579e-54 |
0.33
|
OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
4.901e-53 |
0.42
|
F1SH20_PIG |
TRHDE |
Uncharacterized protein |
1.987e-51 |
0.30
|
O07911_STAAU |
agrC |
AgrC |
6.808e-51 |
0.34
|
OPRD_MOUSE |
Oprd1 |
Delta-type opioid receptor |
1.711e-50 |
0.42
|
V1AR_HUMAN |
AVPR1A |
Vasopressin V1a receptor |
3.015e-50 |
0.88
|
GALR1_RAT |
Galr1 |
Galanin receptor type 1 |
4.607e-50 |
0.32
|
GALR2_RAT |
Galr2 |
Galanin receptor type 2 |
4.607e-50 |
0.32
|
NPFF2_RAT |
Npffr2 |
Neuropeptide FF receptor 2 |
6.903e-50 |
0.32
|
V2R_HUMAN |
AVPR2 |
Vasopressin V2 receptor |
2.371e-49 |
0.88
|
PTPRC_HUMAN |
PTPRC |
Receptor-type tyrosine-protein phosphatase C |
8.593e-48 |
0.33
|
HDAC8_MOUSE |
Hdac8 |
Histone deacetylase 8 |
6.464e-46 |
0.31
|
Q8CGM4_CAVPO |
OPRM1 |
Mu-opioid receptor |
8.076e-46 |
0.34
|
OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
2.659e-45 |
0.42
|
OXYR_MOUSE |
Oxtr |
Oxytocin receptor |
2.851e-45 |
0.74
|
RENI_RAT |
Ren1 |
Renin |
1.434e-41 |
0.31
|
SURA_ECOLI |
surA |
Chaperone SurA |
2.485e-39 |
0.31
|
CADH2_HUMAN |
CDH2 |
Cadherin-2 |
1.046e-36 |
0.29
|
HMDH_MESAU |
HMGCR |
3-hydroxy-3-methylglutaryl-coenzyme A reductase |
1.754e-36 |
0.30
|
GRB2_HUMAN |
GRB2 |
Growth factor receptor-bound protein 2 |
1.197e-33 |
0.44
|
OXYR_RAT |
Oxtr |
Oxytocin receptor |
2.542e-32 |
0.88
|
XPP2_RAT |
Xpnpep2 |
Xaa-Pro aminopeptidase 2 |
1.199e-30 |
0.29
|
ITA3_HUMAN |
ITGA3 |
Integrin alpha-3 |
3.732e-30 |
0.35
|
NMUR1_HUMAN |
NMUR1 |
Neuromedin-U receptor 1 |
6.713e-30 |
0.31
|
V1AR_RAT |
Avpr1a |
Vasopressin V1a receptor |
3.827e-29 |
0.81
|
AMPN_HUMAN |
ANPEP |
Aminopeptidase N |
7.648e-29 |
0.42
|
NMUR2_HUMAN |
NMUR2 |
Neuromedin-U receptor 2 |
9.797e-28 |
0.31
|
NK2R_MESAU |
TACR2 |
Substance-K receptor |
7.063e-27 |
0.31
|
FSHR_RAT |
Fshr |
Follicle-stimulating hormone receptor |
3.081e-26 |
0.32
|
NK2R_RABIT |
TACR2 |
Substance-K receptor |
1.206e-25 |
0.31
|
A4HSF7_LEIIN |
TRYR |
Trypanothione reductase |
6.731e-25 |
0.31
|
CXCR4_HUMAN |
CXCR4 |
C-X-C chemokine receptor type 4 |
1.283e-24 |
0.33
|
SPSB2_HUMAN |
SPSB2 |
SPRY domain-containing SOCS box protein 2 |
4.954e-24 |
0.39
|
UR2R_RAT |
Uts2r |
Urotensin-2 receptor |
1.84e-23 |
0.39
|
TR10A_HUMAN |
TNFRSF10A |
Tumor necrosis factor receptor superfamily member 10A |
2.847e-23 |
0.29
|
SYMC_HUMAN |
MARS1 |
Methionine--tRNA ligase, cytoplasmic |
1.399e-21 |
0.31
|
CBPN_HUMAN |
CPN1 |
Carboxypeptidase N catalytic chain |
1.403e-20 |
0.34
|
OPRK_RAT |
Oprk1 |
Kappa-type opioid receptor |
2.915e-19 |
0.34
|
LGMN_HUMAN |
LGMN |
Legumain |
3.284e-19 |
0.29
|
DSBA_ECOLI |
dsbA |
Thiol:disulfide interchange protein DsbA |
1.007e-18 |
0.28
|
V1BR_RAT |
Avpr1b |
Vasopressin V1b receptor |
1.754e-18 |
0.64
|
NK2R_RAT |
Tacr2 |
Substance-K receptor |
8.489e-18 |
0.35
|
SSR2_HUMAN |
SSTR2 |
Somatostatin receptor type 2 |
1.104e-17 |
0.37
|
XPP2_HUMAN |
XPNPEP2 |
Xaa-Pro aminopeptidase 2 |
1.178e-17 |
0.29
|
ACKR3_HUMAN |
ACKR3 |
Atypical chemokine receptor 3 |
7.772e-16 |
0.36
|
SSR2_MOUSE |
Sstr2 |
Somatostatin receptor type 2 |
7.772e-16 |
0.30
|
XIAP_HUMAN |
XIAP |
E3 ubiquitin-protein ligase XIAP |
1.998e-15 |
0.37
|
MTLR_HUMAN |
MLNR |
Motilin receptor |
3.553e-15 |
0.33
|
C3AR_HUMAN |
C3AR1 |
C3a anaphylatoxin chemotactic receptor |
4.774e-15 |
0.33
|
V2R_RAT |
Avpr2 |
Vasopressin V2 receptor |
5.662e-15 |
0.64
|
SSR4_HUMAN |
SSTR4 |
Somatostatin receptor type 4 |
9.992e-15 |
0.38
|
HDAC6_MOUSE |
Hdac6 |
Histone deacetylase 6 |
1.221e-14 |
0.33
|
NK1R_CAVPO |
TACR1 |
Substance-P receptor |
2.875e-14 |
0.32
|
BRCA1_HUMAN |
BRCA1 |
Breast cancer type 1 susceptibility protein |
4.43e-14 |
0.29
|
XPP1_HUMAN |
XPNPEP1 |
Xaa-Pro aminopeptidase 1 |
2.173e-13 |
0.29
|
MC4R_MOUSE |
Mc4r |
Melanocortin receptor 4 |
2.184e-13 |
0.31
|
ENV_HV1H2 |
env |
Envelope glycoprotein gp160 |
6.108e-13 |
0.28
|
TRFR_RAT |
Trhr |
Thyrotropin-releasing hormone receptor |
6.664e-13 |
0.28
|
NK1R_RAT |
Tacr1 |
Substance-P receptor |
2.04e-12 |
0.34
|
B3DH72_DANRE |
oprd1b |
Opioid receptor, delta 1b |
2.065e-12 |
0.30
|
O57585_DANRE |
oprd1a |
Opioid receptor homologue |
2.065e-12 |
0.30
|
OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
2.751e-12 |
0.36
|
OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
3.723e-12 |
0.35
|
HDAC1_MOUSE |
Hdac1 |
Histone deacetylase 1 |
4.091e-12 |
0.33
|
NRP1_RAT |
Nrp1 |
Neuropilin-1 |
8.094e-12 |
0.29
|
PRTN3_HUMAN |
PRTN3 |
Myeloblastin |
1.023e-11 |
0.35
|
PEPD_HUMAN |
PEPD |
Xaa-Pro dipeptidase |
1.212e-11 |
0.28
|
Q98UH1_DANRE |
oprm1 |
Mu opioid receptor-like OR2 |
2.728e-11 |
0.30
|
P96830_MYCTO |
|
TYR_PHOSPHATASE_2 domain-containing protein |
5.436e-11 |
0.31
|
AMPL_HUMAN |
LAP3 |
Cytosol aminopeptidase |
6.674e-11 |
0.29
|
ITAV_HUMAN |
ITGAV |
Integrin alpha-V |
7.538e-11 |
0.38
|
ITB3_HUMAN |
ITGB3 |
Integrin beta-3 |
8.412e-11 |
0.38
|
ITA5_HUMAN |
ITGA5 |
Integrin alpha-5 |
1.047e-10 |
0.38
|
OPRM_MOUSE |
Oprm1 |
Mu-type opioid receptor |
1.992e-10 |
0.36
|
AMD_HUMAN |
PAM |
Peptidyl-glycine alpha-amidating monooxygenase |
2.17e-10 |
0.33
|
ITA2B_HUMAN |
ITGA2B |
Integrin alpha-IIb |
2.575e-10 |
0.32
|
SSR1_HUMAN |
SSTR1 |
Somatostatin receptor type 1 |
3.123e-10 |
0.38
|
OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
4.596e-10 |
0.36
|
STAT6_HUMAN |
STAT6 |
Signal transducer and activator of transcription 6 |
1.534e-09 |
0.30
|
SSR3_HUMAN |
SSTR3 |
Somatostatin receptor type 3 |
2.126e-09 |
0.38
|
KEAP1_HUMAN |
KEAP1 |
Kelch-like ECH-associated protein 1 |
7.242e-09 |
0.32
|
NTR2_RAT |
Ntsr2 |
Neurotensin receptor type 2 |
8.045e-09 |
0.35
|
IDE_HUMAN |
IDE |
Insulin-degrading enzyme |
1.85e-08 |
0.31
|
NK3R_CAVPO |
TACR3 |
Neuromedin-K receptor |
3.328e-08 |
0.31
|
PIN1_HUMAN |
PIN1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
3.962e-08 |
0.35
|
SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
5.258e-08 |
0.37
|
CBPA1_HUMAN |
CPA1 |
Carboxypeptidase A1 |
6.053e-08 |
0.34
|
OST48_HUMAN |
DDOST |
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit |
1.031e-07 |
0.29
|
MC3R_MOUSE |
Mc3r |
Melanocortin receptor 3 |
3.271e-07 |
0.31
|
UBC9_HUMAN |
UBE2I |
SUMO-conjugating enzyme UBC9 |
3.296e-07 |
0.30
|
HMDH_HUMAN |
HMGCR |
3-hydroxy-3-methylglutaryl-coenzyme A reductase |
6.391e-07 |
0.31
|
EDNRA_PIG |
EDNRA |
Endothelin-1 receptor |
7.757e-07 |
0.31
|
NK3R_RAT |
Tacr3 |
Neuromedin-K receptor |
8.475e-07 |
0.35
|
Q9S446_STAAU |
srtA |
Class A sortase SrtA |
1.281e-06 |
0.34
|
PLK1_HUMAN |
PLK1 |
Serine/threonine-protein kinase PLK1 |
2.4e-06 |
0.34
|
KLK5_HUMAN |
KLK5 |
Kallikrein-5 |
3.355e-06 |
0.28
|
ITB6_HUMAN |
ITGB6 |
Integrin beta-6 |
5.724e-06 |
0.32
|
PLK2_HUMAN |
PLK2 |
Serine/threonine-protein kinase PLK2 |
6.897e-06 |
0.30
|
Q72874_9HIV1 |
pol |
Pol polyprotein |
8.321e-06 |
0.40
|
CBPB2_HUMAN |
CPB2 |
Carboxypeptidase B2 |
9.751e-06 |
0.34
|